当前位置:首页 - 行情中心 - 美好医疗(301363) - 财务分析 - 现金流量表

美好医疗

(301363)

  

流通市值:37.72亿  总市值:137.33亿
流通股本:1.56亿   总股本:5.69亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金715,374,586.45390,390,657.491,521,209,592.371,044,515,538.48
  收到的税费返还21,100,643.815,752,379.7327,136,855.8423,680,332.26
  收到其他与经营活动有关的现金116,650,836.6111,780,010.9440,585,421.4530,016,184.23
  经营活动现金流入小计853,126,066.86417,923,048.161,588,931,869.661,098,212,054.97
  购买商品、接受劳务支付的现金366,250,605.07164,969,113.82644,781,212.65420,845,787.69
  支付给职工以及为职工支付的现金214,154,351.9119,686,535.11388,146,365.04311,513,655.19
  支付的各项税费31,842,796.6220,712,497.1163,028,164.6333,971,051.18
  支付其他与经营活动有关的现金129,122,597.69111,045,002.4544,770,179.4330,144,651.93
  经营活动现金流出小计741,370,351.28416,413,148.491,140,725,921.75796,475,145.99
  经营活动产生的现金流量净额111,755,715.581,509,899.67448,205,947.91301,736,908.98
二、投资活动产生的现金流量:
  取得投资收益收到的现金4,179,243.131,648,331.4410,052,933.696,681,414.78
  处置固定资产、无形资产和其他长期资产收回的现金净额21,093.2917.619,238,765.011,889,470.69
  收到的其他与投资活动有关的现金1,699,602,137.63619,295,408.254,749,582,487.033,539,945,585.13
  投资活动现金流入小计1,703,802,474.05620,943,757.34,768,874,185.733,548,516,470.6
  购建固定资产、无形资产和其他长期资产支付的现金248,210,003.2344,141,445.57363,076,623.82190,812,912.13
  支付其他与投资活动有关的现金1,296,060,811.48689,740,426.385,133,858,060.563,584,913,189.01
  投资活动现金流出小计1,544,270,814.71733,881,871.955,496,934,684.383,775,726,101.14
  投资活动产生的现金流量净额159,531,659.34-112,938,114.65-728,060,498.65-227,209,630.54
三、筹资活动产生的现金流量:
  取得借款收到的现金41,000,0008,500,000--
  收到其他与筹资活动有关的现金15,181,139.86---
  筹资活动现金流入平衡项目00--
  筹资活动现金流入小计56,181,139.868,500,000--
  偿还债务支付的现金10,000,000---
  分配股利、利润或偿付利息支付的现金38,730,777.03-64,808,807.8464,808,807.84
  支付其他与筹资活动有关的现金15,212,856.9613,312,312.1657,545,470.0455,850,274.03
  筹资活动现金流出小计63,943,633.9913,312,312.16122,354,277.88120,659,081.87
  筹资活动产生的现金流量净额-7,762,494.13-4,812,312.16-122,354,277.88-120,659,081.87
四、汇率变动对现金及现金等价物的影响3,453,244.451,734,910.0128,588,266.46-3,439,811.15
五、现金及现金等价物净增加额266,978,125.24-114,505,617.13-373,620,562.16-49,571,614.58
  加:期初现金及现金等价物余额818,110,568.35818,110,568.351,191,731,130.511,191,731,130.51
  期末现金及现金等价物余额1,085,088,693.59703,604,951.22818,110,568.351,142,159,515.93
补充资料:
  净利润114,302,142.45-363,776,477.42-
  资产减值准备11,177,109.78-21,278,918.49-
  固定资产和投资性房地产折旧46,105,712.41-87,176,579.79-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧46,105,712.41-87,176,579.79-
  无形资产摊销2,286,117.47-4,415,566.25-
  长期待摊费用摊销183,938.53-1,262,686.31-
  处置固定资产、无形资产和其他长期资产的损失-28,368.05-279,865.63-
  固定资产报废损失6,724.13-474.36-
  公允价值变动损失407,103.51--837,654.74-
  财务费用-7,417,181.42--14,199,206.11-
  投资损失-3,952,281.16--10,052,933.69-
  递延所得税9,501,552.83-3,037,000.87-
  其中:递延所得税资产减少4,909,793.72--3,783,288.24-
    递延所得税负债增加4,591,759.11-6,820,289.11-
  存货的减少-29,505,613.13-31,348,205.07-
  经营性应收项目的减少-21,981,988.04--135,059,438.85-
  经营性应付项目的增加-29,346,242.79-66,761,321.27-
  其他16,721,112.47-22,052,977.64-
  现金的期末余额1,085,088,693.59-818,110,568.35-
  减:现金的期初余额818,110,568.35-1,191,731,130.51-
  现金及现金等价物的净增加额266,978,125.24--373,620,562.16-
公告日期2025-08-192025-04-252025-04-182024-10-25
审计意见(境内)标准无保留意见
TOP↑